Integer Holdings Corporation will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 6-8, 2024, at the Anaheim Convention Center in Anaheim, California. Integer welcomes visitors to booth #1439 to learn more about the company’s unwavering commitment to customers as their partner of choice in enhancing the lives of patients through access to Integer’s innovative technology, superior quality and dependable manufacturing to accelerate speed to market and reduce development risk. Integer’s exhibit will spotlight the recent strategic acquisitions of InNeuroCo and Pulse Technologies, each of which have further enhanced Integer’s capability spectrum in the medical device sector. The acquisition of InNeuroCo brings specific expertise in neurovascular solutions and advanced catheter technologies, while the combination with Pulse Technologies enhances capabilities in precision micro machining, backed by proprietary technologies and a focus on high-growth medical markets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ITGR:
- Integer to Showcase Recently Acquired Capabilities and New Technologies at MD&M West 2024
- Integer’s taking share should be augented by PMA supplement, says Piper Sandler
- Integer to Showcase Latest Innovations in Neuromodulation Miniaturization During NANS 2024 Annual Meeting
- Integer price target raised to $100 from $86 at Wells Fargo
- Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies